Ronald G. Almquist

468 total citations
24 papers, 375 citations indexed

About

Ronald G. Almquist is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ronald G. Almquist has authored 24 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Ronald G. Almquist's work include Chemical Synthesis and Analysis (12 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Ronald G. Almquist is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Ronald G. Almquist collaborates with scholars based in United States and Japan. Ronald G. Almquist's co-authors include Clive Jennings-White, Wan‐Ru Chao, Howard L. Johnson, Lawrence Toll, Robert Vince, Elmer J. Reist, M. L. HOEFLE, Cris Olsen, Arnold D. Essenburg and Ronald D. Smith and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ronald G. Almquist

22 papers receiving 323 citations

Peers

Ronald G. Almquist
James S. Kaltenbronn United States
Kelvin Cooper United States
Jelka Pluščec United States
M.G. Gruetter Switzerland
Julien Louvel Netherlands
Schuyler Antane United States
R Bossa Italy
R. A. VOLKMANN United States
J. G. REID United States
James S. Kaltenbronn United States
Ronald G. Almquist
Citations per year, relative to Ronald G. Almquist Ronald G. Almquist (= 1×) peers James S. Kaltenbronn

Countries citing papers authored by Ronald G. Almquist

Since Specialization
Citations

This map shows the geographic impact of Ronald G. Almquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Almquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Almquist more than expected).

Fields of papers citing papers by Ronald G. Almquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Almquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Almquist. The network helps show where Ronald G. Almquist may publish in the future.

Co-authorship network of co-authors of Ronald G. Almquist

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Almquist. A scholar is included among the top collaborators of Ronald G. Almquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Almquist. Ronald G. Almquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeGraw, Joseph I., et al.. (1997). Stabilized Analogs of Thymopentin. 2. 1,2- and 3,4-Ketomethylene Pseudopeptides. Journal of Medicinal Chemistry. 40(15). 2398–2406. 3 indexed citations
2.
DeGraw, Joseph I., Ronald G. Almquist, William T. Colwell, et al.. (1997). Stabilized Analogs of Thymopentin. 1. 4,5-Ketomethylene Pseudopeptides. Journal of Medicinal Chemistry. 40(15). 2386–2397. 15 indexed citations
3.
Toll, Lawrence, et al.. (1991). Isolation and characterization of a new atrial peptide-degrading enzyme from bovine kidney. Biochemical and Biophysical Research Communications. 175(3). 886–893. 16 indexed citations
4.
Almquist, Ronald G., et al.. (1989). Paralytic activity of (des‐Glu1)conotoxin GI analogs in the mouse diaphragm. International journal of peptide & protein research. 34(6). 455–462. 34 indexed citations
5.
Almquist, Ronald G., et al.. (1988). Synthesis and biological activity of ketomethylene-containing nonapeptide analogs of snake venom angiotensin converting enzyme inhibitors. Journal of Medicinal Chemistry. 31(3). 561–567. 11 indexed citations
6.
Toll, Lawrence & Ronald G. Almquist. (1986). Inhibition of [3H]captopril binding by peptide analog angiotensin converting enzyme inhibitors. Biochemical and Biophysical Research Communications. 135(3). 770–777. 3 indexed citations
7.
Tanga, Mary J., Ronald G. Almquist, Thomas H. Smith, Helen Y. Wu, & Elmer J. Reist. (1985). 1‐Azabenz[a]anthracene and 9‐azabenz[a]anthracene. Journal of Heterocyclic Chemistry. 22(6). 1597–1598. 10 indexed citations
9.
Almquist, Ronald G., et al.. (1985). Synthesis and biological activity of pentapeptide analogs of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. Journal of Medicinal Chemistry. 28(8). 1062–1066. 7 indexed citations
10.
Almquist, Ronald G., et al.. (1985). Absorption, metabolism, and excretion studies of carbon 14- and tritium-labeled derivatives of a ketomethylene containing tripeptide. Life Sciences. 37(4). 299–305. 2 indexed citations
11.
Almquist, Ronald G., Cris Olsen, Edward T. Uyeno, & Lawrence Toll. (1984). Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity. Journal of Medicinal Chemistry. 27(2). 115–120. 18 indexed citations
12.
Almquist, Ronald G., et al.. (1983). Synthesis and Biological Activity of an Amino Analogue of a Tripeptide Inhibitor of Angiotensin-Converting Enzyme. Journal of Pharmaceutical Sciences. 72(1). 63–67. 3 indexed citations
13.
Almquist, Ronald G., Clive Jennings-White, Robert Meyer, et al.. (1982). Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at postions 2 and 5 of the hexanoic acid portion. Journal of Medicinal Chemistry. 25(11). 1292–1299. 34 indexed citations
14.
Meyer, Robert, Ernest D. Nicolaides, Elizabeth A. Lunney, et al.. (1981). Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogs: potent angiotensin converting enzyme inhibitors. Journal of Medicinal Chemistry. 24(8). 964–969. 33 indexed citations
15.
Almquist, Ronald G., Wan‐Ru Chao, Mark Ellis, & Hope L. Johnson. (1981). ChemInform Abstract: SYNTHESIS AND BIOLOGICAL ACTIVITY OF A KETOMETHYLENE ANALOG OF A TRIPEPTIDE INHIBITOR OF ANGIOTENSIN CONVERTING ENZYME. Chemischer Informationsdienst. 12(16).
16.
Almquist, Ronald G. & Elmer J. Reist. (1977). Synthesis of nitrosourea derivatives of sucrose as central nervous system anticancer agents. Journal of Medicinal Chemistry. 20(10). 1246–1250. 8 indexed citations
17.
Almquist, Ronald G. & Elmer J. Reist. (1976). Synthesis of 6,6′-disubstituted sucrose derivatives from 1′,6,6′-tri-O-tripsylsucrose. Carbohydrate Research. 46(1). 33–41. 7 indexed citations
18.
Vince, Robert, et al.. (1976). An active puromycin analog derived from a non-nephrotoxic aminonucleoside. Life Sciences. 18(3). 345–349. 7 indexed citations
19.
Vince, Robert, et al.. (1975). Chloramphenicol Binding Site with Analogues of Chloramphenicol and Puromycin. Antimicrobial Agents and Chemotherapy. 8(4). 439–443. 13 indexed citations
20.
Almquist, Ronald G. & Robert Vince. (1973). Puromycin analogs. Synthesis and biological activity of 5'-deoxypuromycin and its aminonucleoside, 6-dimethylamino-9-(3'-amino-3',5'-dideoxy-.beta.-D-ribofuranosyl)purine. Journal of Medicinal Chemistry. 16(12). 1396–1399. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026